Results of the Investigation of Novel Surgical Imaging for Tumor Excision (INSITE) pivotal trial highlight the safety and effectiveness findings of Lumicell’s pivotal trial of its investigational Lumicell Direct Visualization System to identify residual breast cancer following removal of the primary specimen during initial lumpectomy.
NIH has announced it will stop issuing funding opportunities solely dedicated to animal models, but has not published any formal guidance related to the announcement, and researchers are unclear on when or whether further policy materials are to be expected.
